ALX Oncology (ALXO) Institutional Ownership $1.08 +0.06 (+5.88%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$1.08 -0.01 (-0.46%) As of 09/4/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ALX Oncology (NASDAQ:ALXO)CurrentInstitutional OwnershipPercentage97.97%Number ofInstitutional Buyers(last 12 months)30TotalInstitutional Inflows(last 12 months)$9.19MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$9.87M Get ALXO Insider Trade Alerts Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ALXO Institutional Buying and Selling by Quarter ALX Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE1,035,127$430K0.0%-28.7%1.933% 8/14/2025 Jane Street Group LLC203,266$84K0.0%N/A0.381% 8/14/2025 Redmile Group LLC3,391,455$1.41M0.1%-6.8%6.352% 8/13/2025 Marshall Wace LLP106,280$45K0.0%-60.8%0.199% 8/12/2025 XTX Topco Ltd74,770$31K0.0%-19.0%0.140% 8/12/2025 JPMorgan Chase & Co.88,352$37K0.0%-75.3%0.165% 8/8/2025 Geode Capital Management LLC315,421$131K0.0%-59.1%0.591% 6/27/2025 Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699% 5/21/2025 Acadian Asset Management LLC1,296,331$806K0.0%+16.8%2.428% 5/16/2025 Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699% Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 AQR Capital Management LLC119,050$74K0.0%+183.6%0.223% 5/16/2025 Almitas Capital LLC1,353,141$843K0.3%+10.6%2.534% 5/15/2025 Redmile Group LLC3,640,834$2.27M0.2%-1.3%6.819% 5/15/2025 MPM Bioimpact LLC550,000$343K0.1%-60.5%1.030% 5/12/2025 Nuveen LLC164,790$103K0.0%N/A0.309% 5/12/2025 Invesco Ltd.73,836$46K0.0%N/A0.138% 5/8/2025 XTX Topco Ltd92,259$57K0.0%-65.0%0.173% 2/17/2025 Two Sigma Investments LP704,131$1.18M0.0%+6.7%1.335% 2/17/2025 Two Sigma Advisers LP823,900$1.38M0.0%+64.6%1.562% 2/17/2025 Tang Capital Management LLC3,296,883$5.51M0.4%-21.6%6.251% 2/17/2025 Redmile Group LLC3,689,611$6.16M0.4%-3.8%6.996% 2/17/2025 MPM Bioimpact LLC1,391,434$2.32M0.3%-42.3%2.638% 2/17/2025Nuveen Asset Management LLC164,790$275K0.0%+55.6%0.312% 2/17/2025 Deutsche Bank AG101,113$169K0.0%+521.0%0.192% 2/17/2025 D. E. Shaw & Co. Inc.255,878$427K0.0%-11.9%0.485% 2/17/2025 Cubist Systematic Strategies LLC32,021$53K0.0%-91.7%0.061% 2/17/2025 Bridgeway Capital Management LLC75,000$125K0.0%N/A0.142% 2/17/2025 Bank of America Corp DE1,035,326$1.73M0.0%+492.9%1.963% 2/17/2025 Almitas Capital LLC1,222,945$2.04M0.4%N/A2.319% 2/14/2025 Northern Trust Corp343,066$573K0.0%+7.3%0.650% 2/14/2025 Dimensional Fund Advisors LP26,233$44K0.0%-30.3%0.050% 2/13/2025 XTX Topco Ltd263,856$441K0.0%-16.8%0.500% 2/13/2025 Bank of Nova Scotia105,306$176K0.0%N/A0.200% 2/13/2025 Bank of Montreal Can826,582$1.38M0.0%N/A1.567% 2/12/2025 Geode Capital Management LLC740,106$1.24M0.0%+5.6%1.403% 2/12/2025 JPMorgan Chase & Co.236,046$394K0.0%+476.7%0.448% 2/11/2025 Sei Investments Co.60,795$102K0.0%N/A0.115% 2/6/2025 Charles Schwab Investment Management Inc.216,707$362K0.0%-3.8%0.411% 2/4/2025 Los Angeles Capital Management LLC301,419$503K0.0%+16.9%0.572% 2/4/2025 Bank of New York Mellon Corp90,003$150K0.0%+12.0%0.171% 1/29/2025 JSF Financial LLC17,500$29K0.0%N/A0.033% 11/19/2024 Barclays PLC59,502$107K0.0%+243.6%0.113% 11/15/2024 Barclays PLC59,502$107K0.0%+243.6%0.113% 11/15/2024 XTX Topco Ltd317,322$578K0.0%N/A0.602% 11/15/2024 Jane Street Group LLC27,918$51K0.0%-64.3%0.053% 11/15/2024 Wellington Management Group LLP167,831$305K0.0%+15.2%0.318% 11/15/2024 State Street Corp671,376$1.22M0.0%-4.8%1.273% 11/15/2024 Redmile Group LLC3,836,576$6.98M0.4%-5.0%7.274% 11/14/2024 Verition Fund Management LLC133,025$242K0.0%+308.4%0.252% 11/14/2024 Walleye Capital LLC230,875$420K0.0%+110.3%0.438% 11/13/2024 FMR LLC5,865,106$10.67M0.0%-25.0%11.121% 11/12/2024 Charles Schwab Investment Management Inc.225,302$410K0.0%-4.5%0.428% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.83,042$151K0.0%+207.4%0.158% 11/5/2024 GSA Capital Partners LLP48,204$88K0.0%N/A0.092% 11/4/2024 Los Angeles Capital Management LLC257,779$469K0.0%N/A0.489% 11/2/2024 Privium Fund Management B.V.509,059$926K0.2%+28.2%0.967% 10/3/2024 SG Americas Securities LLC27,394$50K0.0%+33.6%0.053% 8/19/2024 Point72 Asset Management L.P.304,100$1.83M0.0%N/A0.584% 8/16/2024 Algert Global LLC41,215$249K0.0%N/A0.079% 8/15/2024 Susquehanna Portfolio Strategies LLC73,468$443K0.0%-19.2%0.141% 8/15/2024 The Manufacturers Life Insurance Company13,662$82K0.0%-77.3%0.026% 8/15/2024 AQR Capital Management LLC18,079$109K0.0%+50.7%0.035% 8/14/2024 Cubist Systematic Strategies LLC199,441$1.20M0.0%N/A0.383% 8/14/2024 Marshall Wace LLP635,679$3.83M0.0%+423.0%1.220% 8/12/2024 Inspire Investing LLC58,707$354K0.0%+77.1%0.113% 8/12/2024 Hsbc Holdings PLC10,780$63K0.0%N/A0.021% 8/9/2024 Renaissance Technologies LLC438,200$2.64M0.0%+87.2%0.841% 8/9/2024 Dimensional Fund Advisors LP34,543$208K0.0%-31.4%0.066% 8/8/2024 American Century Companies Inc.23,685$143K0.0%-20.2%0.045% 8/6/2024 Quest Partners LLC20,781$125K0.0%-17.0%0.040% 8/1/2024 Rhumbline Advisers55,220$333K0.0%+10.8%0.106% 8/1/2024 Privium Fund Management B.V.396,966$2.27M0.6%N/A0.762% 7/29/2024 Zurcher Kantonalbank Zurich Cantonalbank6,517$39K0.0%+394.8%0.013% 7/26/2024 Bank of New York Mellon Corp104,966$633K0.0%+31.6%0.201% 7/12/2024 SG Americas Securities LLC20,506$124K0.0%-14.2%0.039% 5/16/2024 California State Teachers Retirement System22,797$254K0.0%+413.8%0.044% 5/16/2024 Redmile Group LLC4,326,509$48.24M1.8%+18.2%8.304% 5/15/2024 Price T Rowe Associates Inc. MD232,769$2.60M0.0%-57.2%0.447% 5/14/2024 EntryPoint Capital LLC2,847$32K0.0%N/A0.005% 5/14/2024 CANADA LIFE ASSURANCE Co2,379$27K0.0%N/A0.005% 5/10/2024 Vanguard Group Inc.1,566,464$17.47M0.0%+4.3%3.133% 5/8/2024 Inspire Investing LLC33,156$370K0.0%N/A0.066% 5/7/2024 Swiss National Bank44,200$493K0.0%N/A0.088% 5/7/2024 SG Americas Securities LLC23,906$267K0.0%-21.2%0.048% 4/29/2024 China Universal Asset Management Co. Ltd.9,587$107K0.0%+66.4%0.018% 4/5/2024 Los Angeles Capital Management LLC98,960$1.10M0.0%-19.8%0.197% 2/14/2024 Vestal Point Capital LP1,655,000$24.64M2.6%N/A3.322% 2/12/2024 TD Asset Management Inc70,400$1.05M0.0%N/A0.141% 2/9/2024 Dynamic Technology Lab Private Ltd14,389$215K0.0%N/A0.029% 2/7/2024 Jump Financial LLC24,946$371K0.0%N/A0.050% 2/6/2024 Los Angeles Capital Management LLC123,420$1.84M0.0%-15.9%0.248% 1/31/2024 abrdn plc66,211$986K0.0%N/A0.133% 1/31/2024 Federated Hermes Inc.196,536$2.93M0.0%-21.8%0.394% 1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank1,907$28K0.0%N/A0.004% 1/24/2024 China Universal Asset Management Co. Ltd.5,762$86K0.0%+445.6%0.012% 1/12/2024 SG Americas Securities LLC30,348$452K0.0%+201.4%0.061% 11/13/2023 Federated Hermes Inc.251,360$1.21M0.0%-1.4%0.611% 11/13/2023 Hsbc Holdings PLC35,404$168K0.0%N/A0.086% 11/13/2023 FMR LLC5,591,947$26.84M0.0%-8.8%13.589% 11/8/2023J.P. Morgan Private Wealth Advisors LLC20,000$96K0.0%N/A0.049% (Data available from 1/1/2016 forward) ALXO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALXO shares? During the previous two years, 67 institutional investors and hedge funds held shares of ALX Oncology. The most heavily invested institutionals were Vestal Point Capital LP ($24.64M), Vanguard Group Inc. ($17.47M), FMR LLC ($10.67M), Tang Capital Management LLC ($5.51M), Federated Hermes Inc. ($2.93M), Renaissance Technologies LLC ($2.64M), and Price T Rowe Associates Inc. MD ($2.60M).Learn more on ALX Oncology's institutional investors. What percentage of ALX Oncology's stock is owned by institutional investors? 97.97% of ALX Oncology's stock is owned by institutional investors. Learn more on ALXO's institutional investor holdings. Which institutional investors have been buying ALX Oncology's stock? Of the 53 institutional investors that purchased ALX Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vestal Point Capital LP ($1.66M), Almitas Capital LLC ($1.35M), Bank of America Corp DE ($860.70K), Bank of Montreal Can ($826.58K), Redmile Group LLC ($667.25K), Marshall Wace LLP ($514.13K), and Privium Fund Management B.V. ($509.06K). How much institutional buying is happening at ALX Oncology? Institutional investors have bought a total of 5,953,388 shares in the last 24 months. This purchase volume represents approximately $9.19M in transactions. Which of ALX Oncology's major shareholders have been selling company stock? Of the 16 institutional investors that sold ALX Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($1.95M), MPM Bioimpact LLC ($1.86M), Tang Capital Management LLC ($907.85K), Redmile Group LLC ($645.00K), Geode Capital Management LLC ($455.49K), Bank of America Corp DE ($416.65K), and Goldman Sachs Group Inc. ($391.59K). How much institutional selling is happening at ALX Oncology? Institutional investors have sold a total of 7,804,489 shares in the last 24 months. This volume of shares sold represents approximately $9.87M in transactions. Related Companies Humacyte Institutional Ownership SOPHiA GENETICS Institutional Ownership Adherex Technologies Institutional Ownership Tiziana Life Sciences Institutional Ownership Aerovate Therapeutics Institutional Ownership ProQR Therapeutics Institutional Ownership Entrada Therapeutics Institutional Ownership Sagimet Biosciences Institutional Ownership enGene Institutional Ownership GENFIT Institutional Ownership This page (NASDAQ:ALXO) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALXO Stock Alerts